The accumulation of PARIS interferes with the expression of PGC-1α and NRF-1 via an insulin response element in the Ppargc1a promoter [181], mimicking reductions in PPARGC1A and NRF1 mRNA expression in postmortem SNc from PD patients. Here, NRF1 is linked to Parkinson disease.